-
公开(公告)号:USD720462S1
公开(公告)日:2014-12-30
申请号:US29446284
申请日:2013-02-21
Applicant: Medtronic, Inc.
Designer: David Lura , Martin Gerber , Bryant J. Pudil , Thomas E. Meyer , Brian Mullins
-
公开(公告)号:US10293092B2
公开(公告)日:2019-05-21
申请号:US14828990
申请日:2015-08-18
Applicant: Medtronic, Inc.
Inventor: Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61M1/34 , A61M1/36 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/28 , G06F19/00
Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
-
公开(公告)号:US10179198B2
公开(公告)日:2019-01-15
申请号:US14828979
申请日:2015-08-18
Applicant: Medtronic, Inc.
Inventor: Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61M1/34 , A61M1/36 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/28 , G06F19/00
Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
-
公开(公告)号:US09642960B2
公开(公告)日:2017-05-09
申请号:US14554272
申请日:2014-11-26
Applicant: Medtronic, Inc.
Inventor: Martin Gerber , John Burnes , Suping Lyu , Manda R. VenKatesh , Bryant Pudil
IPC: A61M37/00 , A61M1/16 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , A61M1/34 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/36 , A61M1/28
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.
-
公开(公告)号:USD714946S1
公开(公告)日:2014-10-07
申请号:US29446280
申请日:2013-02-21
Applicant: Medtronic, Inc.
Designer: David Lura , Martin Gerber , Bryant J. Pudil , Thomas E. Meyer , Brian Mullins
-
公开(公告)号:USD714456S1
公开(公告)日:2014-09-30
申请号:US29446282
申请日:2013-02-21
Applicant: Medtronic, Inc.
Designer: David Lura , Martin Gerber , Bryant J. Pudil , Thomas E. Meyer , Brian Mullins
-
公开(公告)号:US20160206801A1
公开(公告)日:2016-07-21
申请号:US15067559
申请日:2016-03-11
Applicant: Medtronic, Inc.
Inventor: Martin Gerber , Suping Lyu , Bryant Pudil
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/6866 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: Monitoring of the performance of a blood fluid removal medium of a blood fluid removal device includes monitoring of condition, such as fluid flow rate or concentration of blood waste product, downstream of the medium. Upstream monitoring of the condition may also be performed to enhance the ability to determine whether the blood fluid removal medium is performing within predetermined ranges.
Abstract translation: 监测血液流体去除装置的血液流体去除介质的性能包括在介质下游监测诸如流体流动速率或血液废物产物浓度的状况。 还可以进行条件的上游监视,以增强确定血液流体去除介质是否在预定范围内执行的能力。
-
公开(公告)号:USD714455S1
公开(公告)日:2014-09-30
申请号:US29446281
申请日:2013-02-21
Applicant: Medtronic, Inc.
Designer: Martin Gerber , David Lura , Bryant Pudil , Thomas Meyer , Brian Mullins
-
公开(公告)号:US11759557B2
公开(公告)日:2023-09-19
申请号:US17034250
申请日:2020-09-28
Applicant: Medtronic, Inc.
Inventor: Martin Gerber , John Burnes , SuPing Lyu , Venkatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61B5/00 , A61M1/00 , A61B5/053 , G16H20/17 , G16H40/63 , A61B5/145 , A61M1/34 , A61M1/36 , A61M1/14 , B01D61/00 , B01D61/32 , A61B5/0295 , A61B5/0537 , B01D65/02 , G16Z99/00 , G16H20/40 , A61B5/026 , A61M1/28
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/6866 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/342 , A61M1/3403 , A61M1/361 , A61M1/3607 , A61M1/3609 , A61M1/3612 , B01D61/00 , B01D61/32 , B01D65/02 , G16H20/17 , G16H20/40 , G16H40/63 , G16Z99/00 , A61B2560/0223 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D2321/12 , B01D2321/40
Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
-
公开(公告)号:US10967112B2
公开(公告)日:2021-04-06
申请号:US15693535
申请日:2017-09-01
Applicant: Medtronic, Inc.
Inventor: Martin Gerber , John Burnes , SuPing Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61B5/145 , A61B5/00 , A61M1/34 , A61M1/36 , A61M1/00 , A61M1/14 , A61B5/0295 , A61B5/053 , A61B5/026 , A61M1/28 , B01D61/00 , B01D61/32 , B01D65/02 , A61B5/0537 , G06F19/00
Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
-
-
-
-
-
-
-
-
-